{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:52:15Z","timestamp":1773258735700,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"GSK"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.yebeh.2016.09.021","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T08:46:50Z","timestamp":1487926010000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China"],"prefix":"10.1016","volume":"69","author":[{"given":"Peimin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senyang","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2016.09.021_bb0005","author":"World Health Organisation Fact Sheet No. 999"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eplepsyres.2013.02.002","article-title":"Prevalence of epilepsy in the People's Republic of China: a systematic review","volume":"105","author":"Gu","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eplepsyres.2014.12.001","article-title":"Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy","volume":"110","author":"Gao","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0020","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1528-1167.2009.02185.x","article-title":"Economic burden of epilepsy in a developing country: a retrospective cost analysis in China","volume":"50","author":"Hong","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157015909788848857","article-title":"Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care","volume":"7","author":"St Louis","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1059-1311(97)80001-5","article-title":"Established antiepileptic drugs","volume":"6","author":"Brodie","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0035","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1528-1167.2007.01136.x","article-title":"Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs","volume":"48","author":"Gazzola","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1474-4422(07)70215-6","article-title":"Development of new antiepileptic drugs: challenges, incentives, and recent advances","volume":"6","author":"Perucca","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2710.2000.00271.x","article-title":"Drug utilization pattern of antiepileptic drugs and traditional Chinese medicines in a general hospital in Taiwan \u2014 a pharmaco-epidemiologic study","volume":"25","author":"Chen","year":"2000","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eplepsyres.2015.07.006","article-title":"Etiologic features and utilization of antiepileptic drugs in people with chronic epilepsy in China: report from the Epilepsy Cohort of Huashan Hospital (ECoH)","volume":"116","author":"Ge","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2012.02.019","article-title":"Utilization of antiepileptic drugs in Hong Kong children","volume":"46","author":"Kwong","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.eplepsyres.2012.03.012","article-title":"Investigation of prevalence, clinical characteristics and management of epilepsy in Yueyang city of China by a door-to-door survey","volume":"101","author":"Pi","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.seizure.2014.05.002","article-title":"Prevalence and clinical characteristics of active epilepsy in southern Han Chinese","volume":"23","author":"Pi","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0075","first-page":"2399","article-title":"Evaluation of clinical features of elderly epilepsy in China","volume":"8","author":"Tian","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1528-1157.1981.tb06159.x","article-title":"Proposal for revised classification of epileptic seizures","volume":"22","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy \u2014 a review","volume":"85","author":"Banerjee","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0100","first-page":"449","article-title":"Epidemiological survey on epilepsy among rural populations in five provinces in China","volume":"82","author":"Wang","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.0013-9580.2004.47003.x","article-title":"The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy","volume":"45","author":"Johnson","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1006\/ebeh.2001.0242","article-title":"Prevalence of psychopathology in Dutch epilepsy inpatients: a comparative study","volume":"2","author":"Swinkels","year":"2001","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yebeh.2016.02.019","article-title":"Factors affecting quality of life in adults with epilepsy in Taiwan: a cross-sectional, correlational study","volume":"58","author":"Chen","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0120","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40263-014-0187-x","article-title":"Sociodemographic disparities in administration of antiepileptic drugs to adults with epilepsy in Germany: a retrospective, database study of drug prescriptions","volume":"28","author":"Hamer","year":"2014","journal-title":"CNS Drugs"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2016.09.021_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yebeh.2003.10.004","article-title":"Depression in epilepsy: a frequently neglected multifaceted disorder","volume":"4","author":"Kanner","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.seizure.2012.03.006","article-title":"Evaluation of clinical aspects and quality of life as risk factors for depression in patients with epilepsy","volume":"21","author":"Zhao","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.2042-7174.2012.00240.x","article-title":"Utilization patterns of antiepileptic drugs among adult epileptic patients at a tertiary hospital in Oman","volume":"21","author":"Al Zaabi","year":"2013","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1528-1157.1996.tb00017.x","article-title":"Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study","volume":"37","author":"Forsgren","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935\u20131984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0150","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0140-6736(90)92959-L","article-title":"National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population","volume":"336","author":"Sander","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0160","first-page":"92","article-title":"Antiepileptic drugs and quality of life in patients with epilepsy: a tertiary care hospital-based study","volume":"8","author":"George","year":"2015","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2009.03.002","article-title":"Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003\u20132005","volume":"85","author":"Alacqua","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eplepsyres.2011.05.003","article-title":"Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study","volume":"96","author":"Hsieh","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.seizure.2012.04.014","article-title":"Trends in antiepileptic drug utilisation in UK primary care 1993\u20132008: cohort study using the General Practice Research Database","volume":"21","author":"Nicholas","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.seizure.2015.01.010","article-title":"Evaluation of costs of epilepsy using an electronic practice management software in Germany","volume":"26","author":"Noda","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0185","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1007\/s00415-012-6509-3","article-title":"Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany \u2014 a nationwide population-based study in children and adults","volume":"259","author":"Hamer","year":"2012","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2016.09.021_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nrl.2015.06.015","article-title":"Drug utilisation study in patients receiving antiepileptic drugs in Colombia","volume":"31","author":"Machado-Alba","year":"2016","journal-title":"Neurologia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/1756-0500-6-473","article-title":"Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital","volume":"6","author":"Habib","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eplepsyres.2010.08.002","article-title":"Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy","volume":"91","author":"Malerba","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0205","first-page":"159","article-title":"Assessment of antiepileptic drugs usage in a South Indian tertiary care teaching hospital","volume":"18","author":"Sebastian","year":"2013","journal-title":"Neurol Asia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0972-2327.104338","article-title":"Antiepileptic drugs prescription utilization behavior and direct costs of treatment in a national hospital of India","volume":"15","author":"Haroon","year":"2012","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0215","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yebeh.2011.10.018","article-title":"Treatment of epilepsy in adults: expert opinion in China","volume":"23","author":"Yu","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0225","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0240","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00228-008-0480-z","article-title":"Antiepileptic drug utilization in children from 1997\u20132005 \u2014 a study from the Netherlands","volume":"64","author":"van de Vrie-Hoekstra","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2016.09.021_bb0245","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.yebeh.2011.06.035","article-title":"Interrater reliability of the international consensus definition of drug-resistant epilepsy: a pilot study","volume":"22","author":"Hao","year":"2011","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016304632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505016304632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T13:42:55Z","timestamp":1549806175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505016304632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":48,"alternative-id":["S1525505016304632"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.09.021","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}